Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis

BACKGROUND: Cognitive impairment is one of the most important clinical features of neurodegenerative disorders including multiple sclerosis (MS). Conducted research shows that up to 65 percent of MS patients have cognitive deficits such as episodic memory, sustained attention, reduced verbal fluency...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Elżbieta, Morel, Agnieszka, Redlicka, Justyna, Miller, Igor, Saluk, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018194/
https://www.ncbi.nlm.nih.gov/pubmed/29119933
http://dx.doi.org/10.2174/1570159X15666171109132650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018194/
https://www.ncbi.nlm.nih.gov/pubmed/29119933
http://dx.doi.org/10.2174/1570159X15666171109132650

Ejemplares similares